Assessing the Safety of Human Pluripotent Stem Cells and Their Derivatives for Clinical Applications
Peter W. Andrews(The Wistar Institute), Glyn Stacey(Institute of Zoology), Peter J. Rugg‐Gunn(Babraham Institute), Uri Ben‐David(Tel Aviv University), Barbara B. Knowles(Siriraj Hospital), Benjamin Reubinoff(Hadassah Medical Center), Kevin Eggan(Broad Institute), Martín F. Pera(Jackson Laboratory), András Nagy(University of Pecs), Peter Coffey(University College Hospital), Nissim Benvenisty(Hebrew University of Jerusalem)
Cited by 137
Related Papers
Differentiation of Human Embryonic Stem Cells into Embryoid Bodies Comprising the Three Embryonic Germ Layers
|Molecular Medicine|2000|1.5k
Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells
|Proceedings of the National Academy of Sciences|2000|1.1k
The tumorigenicity of human embryonic and induced pluripotent stem cells
|Nature reviews. Cancer|2011|886
Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
|Nature Cancer|2020|880